Journal article
A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
- Abstract:
-
We report a cisplatin and irinotecan combination in patients with biopsy-proven advanced pancreatic adenocarcinoma. Patients were selected from a specialist centre and required good performance status (KPS>70%), measurable disease on CT scan, and biochemical and haematological parameters within normal limits. Based on a two-stage phase II design, we aimed to treat 22 patients initially. The study was stopped because of the death of the 19th patient during the first treatment cycle, with ne...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- British journal of cancer More from this journal
- Volume:
- 89
- Issue:
- 10
- Pages:
- 1860-1864
- Publication date:
- 2003-11-01
- DOI:
- EISSN:
-
1532-1827
- ISSN:
-
0007-0920
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:458578
- UUID:
-
uuid:ba8bd24a-096f-44e2-b105-4d1928c034fd
- Local pid:
-
pubs:458578
- Source identifiers:
-
458578
- Deposit date:
-
2014-08-16
Terms of use
- Copyright date:
- 2003
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record